List view / Grid view

Nathan Robertson

Filter the results

 

article

Kick-starting the immune response – the shifting landscape of immuno-oncology

The landscape of cancer treatment has changed dramatically in the…

29 March 2019 | By ,

The landscape of cancer treatment has changed dramatically in the last seven years, beginning with the approval of Ipilmumab in 2011, the first immunotherapy drug. Efforts to unsheathe the tumour cells of their protective microenvironment and expose them to an active immune response have delivered several monoclonal antibodies (mAbs) that…